Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02208271 · ClinicalTrials.gov registry record
A Validated Necrosis Assay to Determine the Need for Revision Surgery in Metal-on-metal Total Hip Arthroplasty
A clinical trial, sponsored by OrthoCarolina Research Institute.
- Terminated
- Registry status
- 174
- Enrollment target
NCT02208271 is a clinical trial that was terminated before completion, run by OrthoCarolina Research Institute. The registered enrollment target is 174 participants.
The verdict
NCT02208271 was terminated before completion, sponsored by OrthoCarolina Research Institute.
- TERMINATED
- Registry status
- 174 participants
- Enrollment target
Study Summary
The purpose of the study is to develop a biomarker assay to be used as a diagnostic tool for adverse local tissue reaction, or tissue necrosis, in a metal on metal total hip replacement. A convenience sample of a total of 100 hip patients will be enrolled: 50 metal-on-metal revision hips, 25 metal-on-poly revision hips, and 25 pre-operative total hips (no implant, control group) will be enrolled. Preoperative blood serum samples and intraoperative synovial fluid will be obtained from all hips and used for biomarker testing. Additionally, intraoperative assessment of tissue necrosis will be assessed.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 174 participants |
| Start Date | 2014-08-04 |
| Est. Completion | 2020-08-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02208271
The ClinicalTrials.gov registry entry for NCT02208271 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 174 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OrthoCarolina Research Institute, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02208271 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02208271 about?
NCT02208271 is a clinical study titled "A Validated Necrosis Assay to Determine the Need for Revision Surgery in Metal-on-metal Total Hip Arthroplasty". The purpose of the study is to develop a biomarker assay to be used as a diagnostic tool for adverse local tissue reaction, or tissue necrosis, in a metal on metal total hip replacement. A convenience sample of a total of 100 hip patients will be enrolled: 50 metal-on-metal revision hips, 25 metal-...
What is the current status of trial NCT02208271?
This trial is currently terminated. The enrollment target is 174 participants. The study started on 2014-08-04. Estimated completion is 2020-08-12.
Who is sponsoring clinical trial NCT02208271?
This trial is sponsored by OrthoCarolina Research Institute, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.